Shkrebneva I.I. - list of publications

LIPID-LOWERING THERAPY IN OUTPATIENTS OF DIFFERENT AGES WITH CORONARY ARTERY DISEASE

Article

Zyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Landyshev N.N., Voronko Ya.G., Lutsenko A.M.

Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Vol. 19. 2020. P. 75-82

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF G LURAZYME® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Kudlay D.A., Gapchenko E.V., Markova O.A., Borozinets A.Y., Kazarov A.A., Pantyushenko M.S.

Онкогематология. Общество с ограниченной ответственностью "Издательский дом "АБВ-пресс". Vol. 14. 2019. P. 73-83

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF GLURAZIM® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Kudlay D.A., Gapchenko E.V., Markova O.A., Borozinets A.Y., Kazarov A.A., Pantyushenko M.S.

Онкогематология. Общество с ограниченной ответственностью "Издательский дом "АБВ-пресс". Vol. 14. 2019. P. 73-83

MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE: CURRENT VIEW OF THE PROBLEM

Article

Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Kliuev D.A., Stepanyan L.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 66-80

ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY)

Article

Tsukanova K.O., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Klyuev D.A.

Research Results in Pharmacology. Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет". Vol. 4. 2018. P. 47-58

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

Article

Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Tsukanova K.O.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 14. 2018. P. 244-251

СПЕЦИФИЧЕСКИЕ АСПЕКТЫ ПЕРВИЧНОЙ МЕДИЦИНСКОЙ ДОКУМЕНТАЦИИ В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ

Article

Возжаев А.В., Фитилев С.Б., Шкребнева И.И., Якушев В.А.

Организационные аспекты проведения клинических исследований. Группа Ремедиум. 2017. P. 87-90

SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

Article

Fitilev S.B., Dimitrova D.A., Shkrebneva I.I., Vozzhaev A.V.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 13. 2017. P. 317-322

DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY

Article

Zyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House. Vol. 9. 2017. P. 4-10

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

Article

Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Dimitrova D.A.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 13. 2017. P. 171-177

РОЛЬ ФАРМАЦЕВТИЧЕСКОГО ЗВЕНА В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ РАННИХ ФАЗ

Article

Возжаев А.В., Фитилев С.Б., Шкребнева И.И., Якушев В.А.

Организационные аспекты проведения клинических исследований. Группа Ремедиум. 2017. P. 20-22

NON-PHARMACOLOGICAL SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED AMBULATORY INSTITUTION

Article

Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Tsukanova K.O., Dimitrova D.A.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2017. P. 25-28

FIRST CLINICAL STUDY OF RUSSIAN PEGINTERFERON ALFA-2B(ALGERON) IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Tukach A.I., Shkrebniova I.I., Ivanov R.A., Linkova Y.N., Chernovskaya T.V., Vozzhaev A.V., Yakushev V.A.

Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 23. 2014. P. 99-102

COMPARATIVE PHARMACOKINETIC STUDY OF BIOEQUIVALENCE OF METOPROLOL SUCCINATE PROLONGED DRUG FORMS

Article

Fitilev S.B., Yakushev V.A., Titarova Y.Y., Vozzhaev A.V., Shkrebniova I.I.

Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 21. 2012. P. 82-84

ОЦЕНКА ГИПОЛИПИДЕМИЧЕСКОЙ ТЕРАПИИ КАК КОМПОНЕНТА ВТОРИЧНОЙ ПРОФИЛАКТИКИ У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА (ФАРМАКОЭПИДЕМИОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ)

Article

Фитилев С.Б., Возжаев А.В., Шкребнева И.И., Титарова Ю.Ю., Сычева Е.А., Журавлев Р.И.

Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 18. 2009. P. 95-96

Шкребнева И.И.

List of records

LIPID-LOWERING THERAPY IN OUTPATIENTS OF DIFFERENT AGES WITH CORONARY ARTERY DISEASE

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF G LURAZYME® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF GLURAZIM® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE: CURRENT VIEW OF THE PROBLEM

ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

СПЕЦИФИЧЕСКИЕ АСПЕКТЫ ПЕРВИЧНОЙ МЕДИЦИНСКОЙ ДОКУМЕНТАЦИИ В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ

SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

РОЛЬ ФАРМАЦЕВТИЧЕСКОГО ЗВЕНА В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ РАННИХ ФАЗ

NON-PHARMACOLOGICAL SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED AMBULATORY INSTITUTION

FIRST CLINICAL STUDY OF RUSSIAN PEGINTERFERON ALFA-2B(ALGERON) IN HEALTHY VOLUNTEERS

COMPARATIVE PHARMACOKINETIC STUDY OF BIOEQUIVALENCE OF METOPROLOL SUCCINATE PROLONGED DRUG FORMS

ОЦЕНКА ГИПОЛИПИДЕМИЧЕСКОЙ ТЕРАПИИ КАК КОМПОНЕНТА ВТОРИЧНОЙ ПРОФИЛАКТИКИ У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА (ФАРМАКОЭПИДЕМИОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ)

Other authors

Fitilev S.B.

Vozzhaev A.V.